Contact Information
Company Information
Company
Aviceda Therapeutics
Total Funding
252358553.0
Technologies
Outlook
Amazon AWS
Netlify
BambooHR
Mobile Friendly
Remote
AI
Keywords
biotechnology research
glyco-immune therapeutics
immune modulation
avd-104
geographic atrophy
macular degeneration
sialic acid mimetics
nanoparticle delivery
high affinity ligands
immune checkpoint inhibitors
chronic inflammation
macrophage repolarization
immune response targeting
innate immune system
clinical trials
ophthalmology
retinal diseases
diabetic macular edema
diabetic retinopathy
complement system
biodegradable nanoparticles
therapeutic nanoparticles
sialic acid-coated nanoparticles
drug development
novel therapies
retinal therapeutics
cancer therapies
fibrosis treatment
neurological disorders
neuroinflammation
cns injury treatment
biotech innovation
cell signaling pathways
biologic therapeutics
personalized medicine
precision therapy
chronic disease management
therapeutic applications
biotechnology
ocular diseases
pharmaceutical research
therapeutic efficacy
safety profile
clinical efficacy
pharmacokinetics
immune cell engagement
high-throughput screening
immunology
drug targets
age-related macular degeneration
biopharma
health care
health
wellness & fitness
hospital & health care
Get Full Contact Details
Subscribe to reveal email addresses and export contacts.
View Plans